Clinical OPC 150 mg
Clinical OPC 150 mg is a botanical supplement featuring VX1, a grape seed extract standardized for oligomeric proanthocyanidins (OPCs). This product provides 150 mg of VX1 per serving, with a transparent label indicating the single active ingredient. The N+ Score for this product is 45, earning it an 'F' grade, placing it in the below-average tier. While the ingredient is clearly disclosed, the N+ Score reflects that the dosage of 150 mg may be considered underdosed compared to some clinical studies for general health benefits, and no ingredients are at clinical doses according to our analysis. This product might be suitable for individuals seeking a specific grape seed extract supplement with full label transparency, but who are aware of the dosage considerations.
About This Product
Clinical OPC 150 mg by Terry Naturally is a vitamins & minerals supplement containing 1 active ingredients. It has earned an N+ Score of 45/100 (Grade F).
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
Weaknesses
- −Missing several expected ingredients for its category
- −Limited ingredient diversity compared to category norms
Ingredient Analysis (1 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| VX1 | 150.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.